Surgery Partners, Inc.
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
SGRY$26.73+1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, dollars in millions, except per share amounts; shares in thousands)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenues | $815.3 | $821.5 | $2,475.1 | $2,423.7 |
| Operating expenses: | ||||
| Salaries and benefits | 239.8 | 242.8 | 740.3 | 716.6 |
| Supplies | 214.1 | 208.9 | 661.1 | 639.7 |
| Professional and medical fees | 99.2 | 104.0 | 303.3 | 301.4 |
| Lease expense | 23.8 | 21.5 | 71.0 | 65.2 |
| Other operating expenses | 53.4 | 49.0 | 164.0 | 148.0 |
| Cost of revenues | 630.3 | 626.2 | 1,939.7 | 1,870.9 |
| General and administrative expenses | 40.6 | 22.4 | 116.2 | 94.5 |
| Depreciation and amortization | 39.6 | 39.5 | 117.4 | 116.1 |
| Transaction and integration costs | 22.6 | 12.6 | 56.6 | 55.4 |
| Net (gain) loss on disposals, consolidations and deconsolidations | 2.9 | 15.6 | 9.6 | 19.0 |
| Equity in earnings of unconsolidated affiliates | (6.4) | (5.2) | (16.9) | (16.3) |
| Litigation settlements | 0.4 | 5.1 | 2.9 | 7.3 |
| Loss on debt extinguishment | 3.7 | 1.3 | 3.7 | 1.3 |
| Other income, net | (4.0) | (1.7) | (7.6) | (3.8) |
| 729.7 | 715.8 | 2,221.6 | 2,144.4 | |
| Operating income | 85.6 | 105.7 | 253.5 | 279.3 |
| Interest expense, net | (67.9) | (74.9) | (206.8) | (205.0) |
| Income (loss) before income taxes | 17.7 | 30.8 | 46.7 | 74.3 |
| Income tax (expense) benefit | (3.6) | (5.5) | (5.0) | (4.4) |
| Net income (loss) | 14.1 | 25.3 | 41.7 | 69.9 |
| Less: Net income attributable to non-controlling interests | (35.2) | (48.0) | (113.7) | (132.8) |
| Net income (loss) attributable to Surgery Partners, Inc. | $(21.1) | $(22.7) | $(72.0) | $(62.9) |
| Net income (loss) per share attributable to common stockholders: | ||||
| Basic | $(0.16) | $(0.18) | $(0.56) | $(0.50) |
| Diluted (1) | $(0.16) | $(0.18) | $(0.56) | $(0.50) |
| Weighted average common shares outstanding: | ||||
| Basic | 128,865 | 127,206 | 128,688 | 126,932 |
| Diluted (1) | 128,865 | 127,206 | 128,688 | 126,932 |
(1)The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.